RVMDRevolution Medicines, Inc.Aug 5, 2026Q2 2026
Read transcript →Revolution Medicines, Inc. (RVMD) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$204.11
+0.48%
Mkt Cap $44.15B
RVMDRevolution Medicines, Inc.Aug 5, 2026RVMDRevolution Medicines, Inc.May 6, 2026Q1 2026
Read transcript →RVMDRevolution Medicines, Inc.Feb 25, 2026Q4 2025
Read transcript →RVMDRevolution Medicines, Inc.Nov 5, 2025Q3 2025
Read transcript →RVMDRevolution Medicines, Inc.Aug 7, 2025Q2 2025
Read transcript →RVMDRevolution Medicines, Inc.May 7, 2025Q1 2025
Read transcript →RVMDRevolution Medicines, Inc.Feb 27, 2025Q4 2024
Read transcript →RVMDRevolution Medicines, Inc.Nov 6, 2024Q3 2024
Read transcript →RVMDRevolution Medicines, Inc.Aug 11, 2024Q2 2024
Read transcript →RVMDRevolution Medicines, Inc.May 8, 2024Q1 2024
Read transcript →RVMDRevolution Medicines, Inc.Feb 26, 2024Q4 2023
Read transcript →RVMDRevolution Medicines, Inc.Nov 6, 2023Q3 2023
Read transcript →RVMDRevolution Medicines, Inc.Aug 8, 2023Q2 2023
Read transcript →RVMDRevolution Medicines, Inc.May 8, 2023Q1 2023
Read transcript →RVMDRevolution Medicines, Inc.Feb 27, 2023Q4 2022
Read transcript →RVMDRevolution Medicines, Inc.Nov 7, 2022Q3 2022
Read transcript →RVMDRevolution Medicines, Inc.Aug 9, 2022Q2 2022
Read transcript →RVMDRevolution Medicines, Inc.May 10, 2022Q1 2022
Read transcript →RVMDRevolution Medicines, Inc.Feb 28, 2022Q4 2021
Read transcript →RVMDRevolution Medicines, Inc.Nov 11, 2021Q3 2021
Read transcript →RVMDRevolution Medicines, Inc.Aug 11, 2021Q2 2021
Read transcript →